📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
149,939
All-time analysed
42,983
Positive
6,669
Negative
91,579
Neutral
8,640
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
386 announcements match the current filters (relevance ≥ 5).
EID Parry to Close PSRIPL Refinery; Infuses ₹740Cr to Settle ₹998Cr Liabilities
EID Parry has announced the closure of its wholly-owned subsidiary, Parry Sugars Refinery India Private Limited (PSRIPL), effective March 31, 2026, due to structural unviability and accumulated losses of ₹1,406 Crores. To settle PSRIPL's total liabilities of ₹998 Crores, EID Parry will infuse ₹610 Crores via equity and ₹130 Crores via loans. The company expects to create a provision of approximately ₹655 Crores across FY 2025-26 and FY 2026-27, in addition to a ₹46 Crore impairment of its current investment. While this stops a long-term cash drain, the immediate financial impact on the consolidated balance sheet is substantial.
Key Highlights
Closure of PSRIPL refinery unit effective March 31, 2026, following accumulated losses of ₹1,406 Crores as of March 2025.
EID Parry to infuse ₹740 Crores to settle subsidiary bank borrowings of ₹877 Crores backed by company support.
Estimated provision of ₹655 Crores to be recognized over FY26 and FY27, plus a ₹46 Crore impairment charge.
PSRIPL contributed 13.48% to consolidated revenue in FY25 but had a negative net worth of ₹672.17 Crores.
Structural challenges included non-availability of natural gas, high finance costs, and declining global white sugar premiums.
👀 What to Watch
Investors should expect significant pressure on consolidated earnings over the next two years due to the ₹655 Crore provision. However, the exit from this structurally unviable and loss-making unit may improve the long-term quality of the balance sheet.
EID Parry to Close PSRIPL Refinery; to Provision ₹655 Crore for Liabilities
EID Parry has decided to shut down its wholly-owned subsidiary, Parry Sugars Refinery India Private Limited (PSRIPL), effective March 31, 2026, due to structural unviability and accumulated losses of ₹1,406 crores. The company will infuse up to ₹740 crores (₹610 crore equity and ₹130 crore loan) to settle PSRIPL's outstanding bank borrowings of ₹877 crores. Consequently, EID Parry expects to create a provision of approximately ₹655 crores across FY 2025-26 and FY 2026-27, alongside a ₹46 crore impairment of its investment. While this impacts short-term earnings, it removes a significant loss-making unit that contributed 13.48% to consolidated revenue in FY25.
Key Highlights
Closure of PSRIPL refinery unit due to ₹1,406 crore accumulated losses and negative net worth.
Estimated provision of ₹655 crores to be recognized across FY26 and FY27 to cover subsidiary liabilities.
Board approved ₹610 crore equity infusion and ₹130 crore inter-corporate loan to settle bank debts.
PSRIPL contributed ₹4,262.45 crores to revenue in FY25, representing 13.48% of consolidated turnover.
Refinery deemed unviable due to high operating costs, low white sugar premiums, and lack of natural gas access.
👀 What to Watch
Investors should expect significant pressure on consolidated profitability over the next two fiscal years due to the ₹655 crore provision. However, the exit from this loss-making segment is a long-term positive for capital allocation and margin improvement.
Apeejay Surrendra Park Hotels Appoints Rohit Kakra as COO for Flurys Brand
Apeejay Surrendra Park Hotels Limited has appointed Mr. Rohit Kakra as Chief Operating Officer and Senior Management Personnel, effective April 1, 2026. Mr. Kakra will specifically oversee the operations of the company's iconic bakery and confectionery brand, 'Flurys.' With over 23 years of experience in F&B retail, including a previous stint as COO of Costa Coffee at Devyani International, his appointment is aimed at driving operational efficiencies and performance. This move signals a strategic focus on scaling the Flurys brand within the company's portfolio.
Key Highlights
Appointment of Rohit Kakra as COO and Senior Management Personnel effective April 1, 2026
Mr. Kakra brings over 23 years of extensive experience in the F&B retail sector
Role focused on strengthening operational efficiencies and performance for the 'Flurys' brand
Previous leadership experience includes COO at Costa Coffee and VP Operations at Awfis Space Solutions
Educational background includes IHM Bangalore and a Post Graduate Program from Welingkar Institute
👀 What to Watch
Investors should view this as a positive step toward professionalizing and scaling the high-margin Flurys brand. Monitor the brand's expansion and operational performance in upcoming quarterly reports.
Paras Defence Divests 58.02% Stake in Ayatti Innovative for Rs 6.99 Crore
Paras Defence and Space Technologies has completed the divestment of its entire 58.02% equity stake in its subsidiary, Ayatti Innovative Private Limited. The transaction was executed for a total cash consideration of Rs 6.99 crore with Unifab Ultra Technologies LLP. Ayatti was a minor part of the business, contributing only 0.32% to the consolidated turnover and carrying a negative net worth of Rs 3.37 crore in FY25. This exit allows Paras Defence to offload an underperforming asset and streamline its portfolio.
Key Highlights
Divested entire 58.02% stake comprising 15,20,000 equity shares.
Received total cash consideration of Rs 6,99,20,000 from the buyer, Unifab Ultra Technologies LLP.
Exited a subsidiary that had a negative net worth contribution of Rs 3.37 crore in FY24-25.
The divested entity contributed a negligible 0.32% (Rs 1.18 crore) to the company's total turnover.
Ayatti Innovative Private Limited ceases to be a subsidiary of PARAS effective March 30, 2026.
👀 What to Watch
Investors should view this as a positive strategic move to exit a loss-making or negative net worth subsidiary. The cash infusion and removal of a dragging asset should marginally improve consolidated balance sheet health.
Paradeep Phosphates Proposes MD Re-appointment and New Joint MD Appointment
Paradeep Phosphates has issued a postal ballot notice to seek shareholder approval for the re-appointment of Mr. N Suresh Krishnan as Managing Director for a three-year term starting February 16, 2026. The proposed remuneration includes a basic salary of ₹16.91 lakhs per month and perquisites capped at ₹18.43 lakhs per month, alongside performance-linked pay. Additionally, the company is seeking approval for the appointment of Mr. K K Rajeev Nambiar as Joint Managing Director effective April 1, 2026. Shareholders can participate in the e-voting process from March 28 to April 26, 2026.
Key Highlights
Re-appointment of Mr. N Suresh Krishnan as MD for a 3-year tenure (Feb 2026 to Feb 2029)
Proposed MD basic salary of ₹16.91 lakhs per month within a range of ₹16-25 lakhs
MD perquisites capped at ₹18.43 lakhs per month plus 462,021 ESOP options from FY 2021
Appointment of Mr. K K Rajeev Nambiar as Joint Managing Director effective April 1, 2026
E-voting period for shareholders scheduled from March 28, 2026, to April 26, 2026
👀 What to Watch
Investors should monitor the leadership transition and ensure the proposed remuneration packages are commensurate with the company's financial performance and industry benchmarks.
BIL Vyapar CoC Approves Resolution Plan Request and Evaluation Matrix
BIL Vyapar Limited, formerly known as Binani Industries, has announced the outcomes of its 6th Committee of Creditors (CoC) meeting under the Corporate Insolvency Resolution Process (CIRP). The CoC has officially approved the Request for Resolution Plan (RFRP) and the Evaluation Matrix, which are critical steps for inviting and assessing potential bidders for the company. Additionally, the committee ratified the CIRP costs and the appointment of tax consultants. This progress indicates that the insolvency process is moving toward the stage of seeking a formal resolution plan to settle outstanding debts.
Key Highlights
CoC approved the Request for Resolution Plan (RFRP) and Evaluation Matrix via e-voting concluded on March 23, 2026.
The 6th meeting of the Committee of Creditors was held on March 13, 2026, to advance the insolvency roadmap.
Ratification of CIRP costs and the appointment of Pawan Vani & Associates as Tax Consultants was finalized.
The company remains under the Corporate Insolvency Resolution Process (CIRP) as per SEBI and IBC regulations.
👀 What to Watch
Investors should remain highly cautious as equity shareholders typically face significant dilution or total loss of value during insolvency resolutions. Monitor the upcoming resolution plans to determine if any value will be preserved for minority shareholders.
Par Drugs and Chemicals Reports Regulatory Action or Orders Passed
Par Drugs and Chemicals Limited has informed the stock exchange regarding specific actions taken or orders passed against the company. The disclosure, dated March 26, 2026, follows mandatory reporting requirements for listed entities. While the brief does not specify the exact nature of the order or any financial penalties, such filings typically involve compliance or legal matters. Investors should remain cautious until the full details of the order's impact on operations are clarified.
Key Highlights
Company officially informed the Exchange about actions taken or orders passed.
The filing was signed and dated March 26, 2026, by Sanket Bhupendrabhai Trivedi.
Disclosure is made in compliance with SEBI Listing Obligations and Disclosure Requirements.
Specific financial impact or nature of the regulatory body was not detailed in the brief.
👀 What to Watch
Investors should wait for a detailed disclosure to understand if the order involves significant financial penalties or operational restrictions. Monitor the stock for potential volatility following this regulatory update.
Park Medi World Completes 100% Acquisition of SVPD Healthcare and 360-Bed KPIMS Hospital
Park Medi World Limited has successfully completed the acquisition of a 100% stake in SVPD Healthcare Private Limited as of March 20, 2026. This follows the previous acquisition of K P S Wellness Private Limited, collectively giving the company full control over the KP Institute of Medical Sciences (KPIMS) in Agra. KPIMS is a significant healthcare facility with a 360-bed capacity. This strategic move consolidates the company's expansion into the Agra market and adds substantial operational capacity to its portfolio.
Key Highlights
Completed 100% acquisition of SVPD Healthcare Private Limited on March 20, 2026
SVPD Healthcare has now become a wholly owned subsidiary of Park Medi World
Finalizes the takeover of the 360-bed KP Institute of Medical Sciences (KPIMS) in Agra
Follows the successful 100% acquisition of K P S Wellness Private Limited completed in January 2026
👀 What to Watch
Investors should view this as a significant growth milestone that increases the company's bed capacity by 360 units. Monitor the upcoming quarterly results for the revenue contribution and margin impact from the newly integrated Agra facility.
Apar Industries to Invest $5M in US Subsidiary and Rs 10.76 Cr in Renewable Energy SPV
Apar Industries has announced a dual investment strategy to bolster its international presence and optimize energy costs. The board approved a capital infusion of up to USD 5 million into its wholly-owned subsidiary, APAR USA LLC, to support its conductors and cables business lines. Simultaneously, the company is investing Rs 10.76 crores for a 26% stake in a wind-solar hybrid power project in Gujarat through an associate SPV, Clean Max Rudra Private Limited. These moves reflect a strategic focus on expanding the US market footprint and transitioning towards sustainable energy for its operations.
Key Highlights
Approved additional capital contribution of up to USD 5 million in APAR USA LLC for business needs.
Investment of Rs 10.76 crores to acquire 26% equity in Clean Max Rudra Private Limited for hybrid power.
The hybrid project features 9.90 MVA wind capacity and 7.34 MWp solar capacity in Rajkot, Gujarat.
APAR USA LLC reported nil turnover for FY25, indicating the investment is for upcoming operational scale-up.
This follows a previous investment of Rs 11.38 crores in the same renewable energy SPV.
👀 What to Watch
Investors should monitor the revenue ramp-up in the US subsidiary following this capital infusion. The renewable energy investment is a positive move for long-term margin protection against rising power costs.
Apar Industries to Invest $5M in US Subsidiary and ₹10.76 Cr in Renewable Energy Project
Apar Industries has approved a capital infusion of up to USD 5 million into its wholly-owned subsidiary, APAR USA LLC, to support its conductors and cables business. Additionally, the company will invest approximately ₹10.76 crores to maintain a 26% stake in Clean Max Rudra Private Limited, an associate company. This investment is directed towards a wind-solar hybrid power project in Gujarat with a capacity of 9.90 MVA wind and 7.34 MWp solar. These moves indicate a dual focus on expanding its international footprint and securing sustainable energy for operations.
Key Highlights
Approved additional investment of up to USD 5 million in APAR USA LLC for business expansion in the US.
Investment of ₹10.76 crores in Clean Max Rudra Pvt Ltd to maintain a 26% equity stake for hybrid power.
The renewable project includes 9.90 MVA wind capacity and 7.34 MWp solar capacity in Rajkot, Gujarat.
APAR USA LLC reported nil turnover for the last three fiscal years, indicating a focus on future scaling.
Total previous investment in the renewable SPV already stands at ₹11.38 crores.
👀 What to Watch
Investors should view this as a strategic move to scale the US business and optimize energy costs through renewables. Monitor the US subsidiary's turnover in upcoming quarters to gauge the return on this capital infusion.
Paramount Communications Promoters Buy 1.41 Lakh Shares; Stake Rises to 49.16%
Promoters of Paramount Communications, Sanjay Aggarwal and Sandeep Aggarwal, purchased a total of 1,41,896 shares on March 16, 2026. The acquisition was valued at approximately ₹46.68 lakhs and conducted through open market transactions on the NSE. This move has marginally increased the total promoter group stake from 49.12% to 49.16%. Such insider buying is typically viewed as a positive indicator of management's confidence in the company's intrinsic value.
Key Highlights
Sanjay Aggarwal (WTD) purchased 80,000 shares worth ₹26.34 lakhs
Sandeep Aggarwal (MD) purchased 61,896 shares worth ₹20.34 lakhs
Total promoter group holding increased by 0.04% to reach 49.16%
Transactions were conducted via open market purchases on the NSE on March 16, 2026
👀 What to Watch
Promoter buying from the open market is a positive sign of internal confidence. Investors should view this as a supportive factor for the stock price, though the quantum of purchase is relatively small compared to the total capital.
BIL Vyapar Limited Schedules 6th Committee of Creditors Meeting for March 13, 2026
BIL Vyapar Limited, which is currently undergoing the Corporate Insolvency Resolution Process (CIRP), has announced its sixth Committee of Creditors (CoC) meeting. The meeting is scheduled for March 13, 2026, to discuss matters related to the company's insolvency resolution. This follows the company's transition from its former identity as Binani Industries Limited. Investors should be aware that the outcome of these meetings will significantly dictate the company's future structure and debt obligations.
Key Highlights
The 6th meeting of the Committee of Creditors (CoC) is set for March 13, 2026.
The company is operating under the Corporate Insolvency Resolution Process (CIRP).
Disclosure is made in compliance with Regulation 30 and Schedule III of SEBI LODR Regulations.
BIL Vyapar Limited was formerly known as Binani Industries Limited (NSE: BILVYAPAR).
👀 What to Watch
Investors should remain highly cautious as equity holders typically face significant value erosion during insolvency proceedings. Monitor subsequent filings for details on any proposed resolution plans or liquidation orders.
Uniparts India Appoints Sandeep Taneja as Group CFO; Rohit Maheshwari Resigns
Uniparts India has announced a transition in its financial leadership with the resignation of CFO Rohit Maheshwari, effective March 12, 2026. The Board has appointed Sandeep Taneja as the new Group CFO starting March 16, 2026, ensuring a swift transition. Mr. Taneja brings over 25 years of global experience, having managed P&Ls ranging from $100 million to $3 billion at major firms like Gates India and Ingersoll Rand. His extensive background in both Indian and US markets is expected to support the company's global financial strategy.
Key Highlights
Rohit Maheshwari resigns as CFO and Key Managerial Personnel effective March 12, 2026.
Sandeep Taneja appointed as Group CFO effective March 16, 2026, following a Board meeting on March 11.
New CFO Sandeep Taneja possesses 25+ years of global experience, including 10 years in the USA.
Mr. Taneja has previously managed P&Ls between $100 million and $3 billion at Gates India and Ingersoll Rand.
The appointment includes roles as Key Managerial Personnel under Section 203 of the Companies Act, 2013.
👀 What to Watch
Investors should view this as a routine but significant leadership transition; the high caliber of the incoming CFO is a positive indicator for financial governance. Monitor the upcoming quarterly results for any shifts in financial strategy or commentary under the new leadership.
Park Medi World to Launch 350-Bed Panchkula Hospital and Expand Mohali Facility by 150 Beds
Park Medi World Limited is significantly expanding its footprint in the Tricity region by launching a new multi-super specialty hospital in Panchkula and expanding its Mohali facility. The Panchkula hospital, expandable to 350 beds, will commence operations on March 29, 2026. Additionally, the company will add 150 beds to its existing 350-bed Mohali facility with an investment of Rs. 40 crores funded via internal accruals. These moves will establish the company as the largest private healthcare provider in the region with a total of 850 beds.
Key Highlights
New Panchkula hospital with up to 350 beds to start operations on March 29, 2026.
Expansion of Mohali facility by 150 beds (total 500) to be completed within 18 months.
Investment of approximately Rs. 40 crores for Mohali expansion funded through internal accruals.
Consolidated Tricity capacity to reach 850 beds, creating the region's largest private network.
Group-wide target to reach 5,460 beds by March 2028 from the current 3,610 beds.
👀 What to Watch
Investors should monitor the occupancy ramp-up at the new Panchkula facility and the timely execution of the Mohali expansion as these will be key drivers for revenue growth. The use of internal accruals for expansion is a positive sign of financial health and cash flow generation.
Park Medi World to Add 500 Beds via New Panchkula Hospital and Mohali Expansion
Park Medi World is significantly expanding its footprint in the Tricity region by launching a new multispecialty hospital in Panchkula on March 29, 2026. Additionally, the board has approved a 150-bed expansion at its Mohali facility, which currently operates at 73% capacity, bringing the total regional capacity to 850 beds. The Mohali expansion involves an investment of approximately Rs. 40 crores, which will be entirely funded through internal accruals. This strategic move is expected to make the company the largest private healthcare network in the Tricity area, focusing on high-margin tertiary and quaternary care.
Key Highlights
Launch of Panchkula Hospital (up to 350 beds) scheduled for March 29, 2026
Expansion of Mohali Hospital by 150 beds, increasing its total capacity from 350 to 500 beds
Investment of Rs. 40 crores for Mohali expansion to be funded via internal accruals over 18 months
Consolidated Tricity capacity to reach 850 beds, establishing regional market leadership
Group-wide target to reach 5,460 beds by March 2028 from the current 3,610 beds
👀 What to Watch
Investors should monitor the successful commissioning of the Panchkula facility and the subsequent ramp-up in occupancy rates. The use of internal accruals for expansion is a positive sign of financial health and cash flow generation.
Park Medi World to Launch Panchkula Hospital & Expand Mohali Capacity to 850 Beds
Park Medi World is significantly scaling its presence in the Tricity region by launching a new multispecialty hospital in Panchkula on March 29, 2026. The board also approved a 150-bed expansion at its Mohali subsidiary, increasing its capacity from 350 to 500 beds with a Rs. 40 crore investment. These developments will bring the company's total regional capacity to 850 beds, establishing it as the largest private healthcare network in the area. The expansion is strategically funded through internal accruals and targets high-margin quaternary care services.
Key Highlights
New Panchkula hospital to commence operations on March 29, 2026, with capacity up to 350 beds.
Approved 150-bed expansion at Mohali facility, increasing total beds there to 500 within 18 months.
Consolidated Tricity region capacity to reach 850 beds, establishing regional market leadership.
Expansion cost of Rs. 40 crores for the Mohali unit to be funded entirely through internal accruals.
Strategic focus on high-acuity specialties including Oncology, Neurosciences, and Robotic Surgeries.
👀 What to Watch
This expansion strengthens the company's competitive moat in North India and is expected to drive long-term revenue growth through higher-margin specialty services. Investors should monitor the occupancy rates of the new Panchkula facility in the coming quarters.
Paras Defence Bags Rs 80.28 Cr Order from DRDO for Air Defence Optical Systems
Paras Defence and Space Technologies has secured a significant domestic order valued at approximately Rs 80.28 crore from the DRDO, Ministry of Defence. The contract involves the development of High Precision Optical Systems specifically for Air Defence Applications. The execution of this order is expected to be completed within a period of 18 months. This win reinforces the company's specialized position in the high-tech defence optics segment and provides clear revenue visibility for the near term.
Key Highlights
Order value of approximately Rs 80.28 crore including taxes
Awarded by DRDO, Ministry of Defence for High Precision Optical Systems
Project execution timeline is 18 months from the date of supply order
Focuses on critical technology for Air Defence Applications
👀 What to Watch
This contract win is a positive indicator of the company's technical capabilities and its ability to secure high-value government projects. Investors should monitor the company's execution progress and potential for similar high-margin orders in the defence electronics space.
Paras Defence Signs MoU with South Korea's Green Optics for Space and Defence Systems
Paras Defence and Space Technologies Limited has entered into a Memorandum of Understanding (MoU) with Green Optics Co. Ltd., South Korea. The partnership aims to establish a framework for joint development, manufacturing, and business development of high-end optics and optical systems. This collaboration specifically targets the Space and Defence sectors, leveraging Green Optics' expertise in precision design. While the financial implications are not yet quantified, this move strengthens Paras's technical capabilities and market reach in niche defense technologies.
Key Highlights
MoU signed with Green Optics Co. Ltd., South Korea, on March 04, 2026.
Collaboration focuses on joint development and manufacturing of Optics & Optical Systems.
Target sectors include Space, Defence, and other high-precision applications.
Agreement includes business development cooperation in respective geographical regions.
👀 What to Watch
Investors should view this as a positive strategic step toward enhancing technical expertise; monitor for future contract wins resulting from this partnership.
Paras Defence Incorporates Semiconductor Subsidiary; Holds 70% Stake for OSAT Business
Paras Defence and Space Technologies has incorporated a new subsidiary, Paras Semiconductors Private Limited, on February 27, 2026. The company holds a 70% majority stake in the new entity, having subscribed to 70,000 equity shares at a total cost of ₹7,00,000. This subsidiary is strategically positioned to enter the semiconductor space, specifically focusing on Advanced Heterogeneous Packaging and 3D Packaging OSAT (Outsourced Semiconductor Assembly and Testing). The venture targets high-growth applications including AI, High-Performance Computing (HPC), and Data Centers.
Key Highlights
Incorporation of Paras Semiconductors Private Limited as a 70% owned subsidiary of Paras Defence.
Initial investment of ₹7,00,000 for 70,000 equity shares at ₹10 per share.
Business focus on State-of-the-Art Advanced Heterogeneous Packaging and 3D Packaging OSAT.
Target markets include AI, High-Performance Computing (HPC), Networking, and Data Center applications.
Move aligns with India's strategic push into the semiconductor manufacturing and assembly ecosystem.
👀 What to Watch
Investors should monitor this development as a significant long-term growth lever that diversifies the company into the high-tech semiconductor value chain. Watch for future announcements regarding capital expenditure plans and potential partnerships for the OSAT facility.
Apeejay Surrendra Park Hotels Signs Agreement for 100-Room Premium Hotel in Siliguri
Apeejay Surrendra Park Hotels has entered into a 20-year management and licensing agreement with Luxmi Tea Co. Private Limited. The agreement covers a proposed 100-room premium hotel under 'The Park' brand to be developed in Siliguri, West Bengal. The project will be situated on 3.25 acres within the Chandmani Tea Estate and include F&B, banquet, and wellness facilities. Construction is expected to be completed by March 2031, marking a long-term addition to the company's portfolio.
Key Highlights
Signed a 20-year management and licensing agreement for a new 100-room premium hotel.
Project to be developed on 3.25 acres at Chandmani Tea Estate, Siliguri, in partnership with Luxmi Tea Co.
The hotel will operate under the company's flagship 'The Park' brand.
Facilities include food & beverage outlets, banquet halls, bars, and wellness centers.
Target completion date for construction is set for March 2031.
👀 What to Watch
Investors should view this as a positive step in the company's asset-light expansion strategy, though the long gestation period until 2031 means immediate revenue impact will be negligible.
